期刊
AGING AND DISEASE
卷 12, 期 1, 页码 116-131出版社
INT SOC AGING & DISEASE
DOI: 10.14336/AD.2020.0320
关键词
hypertension; vascular remodeling; inflammation; limb remote ischemic preconditioning
资金
- Natural Science Foundation of China [81971114, 81573867, 81801313]
- Science and technology development project of Beijing Municipal Health Commission
- National Key R&D Program of China [2017YFC 1308402]
Vascular remodeling is an initial step in the development of hypertension, and limb remote ischemic conditioning (LRIC) has shown promising effects on ameliorating blood pressure and vascular remodeling through inflammation regulation in animal models and patients with prehypertension and early-stage hypertension. The study suggests that long-term LRIC treatment may be a potential preventive approach for individuals with elevated blood pressure or prehypertension.
Vascular remodeling is an initial step in the development of hypertension. Limb remote ischemic conditioning (LRIC) is a physiological treatment that induces endogenous protective effect during acute ischemic injury. However, the impact of long-term LRIC on hypertension, a chronic disease, is unknown. In this study, we aimed to investigate the LRIC effect on blood pressure and vascular remodeling in spontaneously hypertensive rat (SHR) model and patients with prehypertension and early-stage hypertension. LRIC of rats was performed once a day for 6-weeks. Blood pressure, vascular remodeling (cross-sectional area, extracellular deposition, and smooth muscle cell area), inflammation (inflammatory factors, and inflammatory cells) were compared among normotensive Wistar-Kyoto rats (WKY), WKY RIC group, SHR control group, and SHR RIC. Long-term LRCI treatment (twice a day for 4-weeks) was performed on patients with prehypertension or early-stage hypertension. Blood pressure and pulse wave velocity (PWV) were analyzed before and after LRIC treatment. LRIC treatment decreased blood pressure in SHR (n = 9-10). LRIC ameliorated vascular remodeling by decreasing cross-sectional area, suppressing deposition of the extracellular matrix, and hypertrophy of smooth muscle cell in conduit artery and small resistance artery (n = 7). LRIC decreased proinflammatory factors while increasing the anti-inflammatory factors in the circulation (n = 5). LRIC decreased circulating monocyte and natural killer T-cell levels (n = 5). Furthermore, LRIC treatment decreased blood pressure and improved vascular stiffness in patients (n = 20). In conclusion, long term LRIC could decrease blood pressure and ameliorate vascular remodeling via inflammation regulation. LRIC could be a preventive treatment for people with blood pressure elevation or prehypertension.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据